Cardiology
Atrial fibrillation with RVR — the essentials
Atrial fibrillation with rapid ventricular response (RVR) is an irregularly irregular, narrow-complex tachycardia with no P waves, usually 110-180 bpm. The decisive nursing judgment is stable vs unstable: a stable patient gets rate control, while an unstable patient (hypotension with hypoperfusion, ischemic chest pain, acute heart failure, or altered mentation) needs immediate synchronized cardioversion. The RN recognizes the rhythm, assesses stability, and gives ordered agents while respecting hold parameters.
Recognize it (red flags)
- ECG/telemetry: irregularly irregular rhythm, narrow QRS, NO discernible P waves, fibrillatory baseline at >100 bpm
- Apical-radial pulse deficit; palpitations, lightheadedness, mild dyspnea, fatigue — or vague weakness/confusion in elders
- Hemodynamic instability (SBP <90 with hypoperfusion, ischemic chest pain, acute pulmonary edema, altered mentation/syncope) = the cannot-miss cardioversion fork
- Post-medication hypotension after IV diltiazem or metoprolol (SBP falling <100 or symptomatic) — stop/hold the agent and escalate
- Wide, very fast, irregular tachycardia (suspected WPW + AF) = AV-nodal blockers are CONTRAINDICATED; escalate immediately
Key numbers
- RVR rate
- ventricular rate >100 bpm, typically 110-180 (often 140-160)
- Rate-control goal
- lenient resting HR <110 bpm (stable/asymptomatic)
- Instability threshold
- SBP <90 with hypoperfusion → cardioversion fork
- Drug-hold threshold
- SBP <100 mmHg or HR <60 bpm (or per order)
- Metoprolol IV
- 2.5-5 mg over ~2 min, repeat q5 min up to ~15 mg cumulative
- Diltiazem IV
- 0.25 mg/kg over 2 min (max initial 25 mg), then 5-15 mg/h
- TEE / anticoagulation gate
- AF duration unknown or >=48 h before elective cardioversion
Priority nursing actions
- Recognize the rhythm and assess stability FIRST — LOC, BP, chest pain, work of breathing, perfusion
- Apply continuous cardiac monitoring + pulse oximetry, obtain a 12-lead ECG, establish IV access, and draw ordered labs (electrolytes, Mg, TSH, troponin, BNP)
- Administer the ordered IV rate-control agent on a monitor with frequent (q2-5 min) BP and HR during titration — hold for SBP <100 or HR <60
- If the patient is or becomes unstable, prepare/assist for synchronized cardioversion: apply pads, set up sedation per order, code cart at bedside, provider to the bedside
- Verify AF duration is documented (flag if unknown), reinforce stroke-risk teaching, and escalate per the cannot-miss triggers
Common NGN / NCLEX traps
- Confusing the instability threshold (SBP <90 with hypoperfusion → cardioversion) with the drug-hold threshold (SBP <100 → hold the agent)
- Giving an AV-nodal blocker (beta-blocker, CCB, digoxin, adenosine) in pre-excited WPW + AF — can accelerate accessory-pathway conduction to VF
- Chasing the rate with repeated nodal pushes into a falling blood pressure instead of preparing for cardioversion
- Giving diltiazem in decompensated HFrEF — its negative inotropy is contraindicated
- Treating sinus tachycardia (regular, P before every QRS) as AFib — treat the underlying cause, not with a nodal blocker
For practicing nurses
What’s changed (if you trained a while ago)
- A lenient resting heart-rate goal of <110 bpm is accepted for stable, asymptomatic patients — tighter control only when ordered (carried from RACE II into the 2023 guideline).
- For obese patients (BMI >=30), IV diltiazem is dosed by ideal body weight (0.25 mg/kg IBW), not actual weight, for equivalent rate control with less hypotension.
- A bleeding-risk assessment (e.g., HAS-BLED) should be documented before any prescribed anticoagulant, and a TEE is required before cardioversion when AF duration is unknown or >=48 h (2024 ESC/EACTS).
- New-onset AFib with RVR during acute neurological injury (neurogenic AF) needs simultaneous neuro and cardiac escalation, not primary cardiac treatment alone.
On the floor (practical pearls)
- Stable vs unstable drives everything: most learners can label "AFib" — the gap is recognizing the stability assessment as the action-driver.
- Give IV metoprolol or diltiazem on a monitor and recheck apical HR and BP before and during titration; hold and notify for SBP <100, HR <60, new HF signs, or new AV block.
- Diltiazem carries a higher hypotension risk than metoprolol — watch the BP within 15 minutes of the IV push (hypotension occurs in ~12.6%) and recheck frequently during any infusion.
- The RN prepares and assists for cardioversion, but the provider orders and selects the energy and directs the shock — apply pads, ensure IV/sedation per order, code cart ready.
- Verify AF duration before any cardioversion plan and flag it if undocumented; if unknown or >=48 h, confirm a TEE has been done first.
- Chart the rhythm, the apical-radial deficit, BP/HR trend during titration, and the response — escalate for unstable RVR, post-drug hypotension, acute neuro deficit, or a pre-excited rhythm.
Key references
- 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation, Circulation, 2023
- 2020 ACLS (AHA) tachycardia algorithm, American Heart Association, 2020
- IV diltiazem vs metoprolol for AFib RVR — umbrella review, EM literature, 2024
- Lewis's Medical-Surgical Nursing — dysrhythmias chapter, Elsevier, 2023
- Davis's Drug Guide for Nurses (metoprolol, diltiazem), F.A. Davis, 2024
Sources: Based on the 2023 ACC/AHA/ACCP/HRS AF Guideline, the 2024 ESC/EACTS AF Guidelines, 2025 AHA Adult ALS, Lewis Medical-Surgical Nursing, and Davis’s Drug Guide.
